drugset / Trial / NCT07525947
A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants
Non-randomizedSequentialOpen-labelBasic science
Summary
This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.
Timeline
- Start
- 2026-05-01
- Primary completion
- 2027-05
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JADE101 | Unknown | — | Subcutaneous |
Indications
No indication recorded.